You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatocyte Growth Factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral Artery Disease Trial in Chicago (VM202, Placebo)

Recruiting
  • Peripheral Artery Disease
  • Chicago, Illinois
    Northwestern University
Jan 10, 2023

Vocal Fold Scar Trial in Kamigyo-ku (KP-100LI, Placebo)

Not yet recruiting
  • Vocal Fold Scar
  • Kamigyo-ku, Kyoto, Japan
    University Hospital Kyoto Prefectural University of Medicine
Nov 16, 2022

Healthy Volunteer Trial in Miami (ANG-3777 (Therapeutic Dose), ANG-3777 (Supra-therapeutic Dose), Placebo)

Not yet recruiting
  • Healthy Volunteer
  • ANG-3777 (Therapeutic Dose)
  • +3 more
  • Miami, Florida
    Quotient Sciences
May 27, 2021

Hemodialysis Trial in Minneapolis (ANG-3777)

Not yet recruiting
  • Hemodialysis
  • Minneapolis, Minnesota
    Hennepin County Medical Center (HCMC)
Jul 9, 2021

Arterial Occlusive Disease, Peripheral Vascular Disease, Ischemia Trial in United States (HGF plasmid, Placebo)

Completed
Has Results
  • Arterial Occlusive Disease
  • +3 more
  • HGF plasmid
  • Placebo
  • Pensacola, Florida
  • +3 more
Oct 12, 2021

Healthy Trial in Nottingham (carbon-14-[14C]-ANG-3777)

Recruiting
  • Healthy
  • Nottingham, Nottinghamshire, United Kingdom
    Quotient Sciences
Jun 11, 2021

Solid Tumors Trial in Seoul (YYB101)

Completed
  • Solid Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 12, 2021

Liver Failure, Thrombocytopenia, Decompensated Cirrhosis Trial in Wuhan (Avatrombopag, Standard medical treatment)

Recruiting
  • Liver Failure
  • +2 more
  • Wuhan, Hubei, China
    Department of infectious disease, Tongji Hospital
Jun 3, 2021

Acute Spinal Cord Injury Trial in Japan (KP-100IT)

Recruiting
  • Acute Spinal Cord Injury
  • Iizuka, Fukuoka, Japan
  • +4 more
Mar 4, 2021

NSCLC ALK-positive, NSCLC c-Met Dependent, NSCLC ROS Marker Positive Trial in Worldwide (PF-02341066, Rifampin, Itraconazole)

Completed
Has Results
  • Non-Small Cell Lung Cancer ALK-positive
  • +4 more
  • Orange, California
  • +28 more
Feb 15, 2022

COVID-19, Pneumonia Trial in Brazil (Standard of Care (SOC) + ANG-3777, Standard Of Care (SOC) + Placebo)

Active, not recruiting
  • COVID-19
  • Pneumonia
  • Standard of Care (SOC) + ANG-3777
  • Standard Of Care (SOC) + Placebo
  • Belo Horizonte, Minas Gerais, Brazil
  • +9 more
Apr 12, 2021

Temporomandibular Joint Disorders Trial in Alexandria (Nd-YAG Fotona, Epidermal Growth Factor)

Enrolling by invitation
  • Temporomandibular Joint Disorders
  • Nd-YAG Fotona
  • Epidermal Growth Factor
  • Alexandria, الإسكندرية, Egypt
    Alexandria University
Sep 13, 2023

Serum Insulin-like Growth Factor Binding Protein-3 asPotential

Not yet recruiting
  • Colorectal Cancer
  • evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
  • (no location specified)
May 6, 2023

Brain-derived Neurotrophic Factor Single Nucleotide Gene

Recruiting
  • Allergic Rhinitis
  • Genotyping.
  • Sohag, Egypt
    Sohag university Hospital
Jun 15, 2023

Insulin Like Growth Factor-1 Against Oxidative Stress in

Not yet recruiting
  • Vitiligo
  • skin biopsy examined by ELISA technique
  • (no location specified)
Apr 13, 2023

Serum Fibroblast Growth Factor-21 Levels During Prolonged

Completed
  • Fibroblast Growth Factor-21
  • Fasting
  • 12 hour fasting for 29 days
  • Ankara, Turkey
    Hacettepe University Nutrition and Dietetics Department
Mar 29, 2023

Concentrated Growth Factor, Bone Substitute Trial in Haikou (concentrated growth factor, bone substitute, concentrated growth

Recruiting
  • Concentrated Growth Factor
  • Bone Substitute
  • concentrated growth factor
  • +2 more
  • Haikou, Hainan, China
    First Affiliated Hospital of Hainan Medical University
Jul 10, 2023

Drug Effect Trial in Tanta (Cinacalcet)

Recruiting
  • Drug Effect
  • Tanta, Egypt
    Sara Mabrouk Mohamed Elghoul
Jun 29, 2023

Dental Implant Failure Nos Trial in Minya (Drug: Growth Factors (CGF), Drug: Growth Factors (PRGF), Surgery: Dental Implant

Recruiting
  • Dental Implant Failure Nos
  • Drug: Growth Factors (CGF)
  • +4 more
  • Minya, Egypt
    Faculty of Dentistry Minia University
Oct 26, 2022

Revascularization Trial (concentrated growth factors in open apex, Blood Clot (BC))

Not yet recruiting
  • Revascularization
  • concentrated growth factors in open apex
  • Blood Clot (BC)
  • (no location specified)
Aug 27, 2023

GINGIVAL RECESSION Trial in Tanta (GROUPI, GROUP II)

Completed
  • GINGIVAL RECESSION
  • GROUPI
  • GROUP II
  • Tanta, Egypt
  • +1 more
Mar 21, 2023

Alopecia, Chemo-Induced Change, Hair Loss Trial in Tucson (Keratinocyte growth factor)

Completed
  • Alopecia
  • +3 more
  • Keratinocyte growth factor
  • Tucson, Arizona
    University of Arizona
Dec 15, 2022

UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging Trial in Fairborn (Insulin-Like Growth Factor 1, No Insulin-Lie

Recruiting
  • UVB Phototherapy Burn
  • +2 more
  • Insulin-Like Growth Factor 1
  • No Insulin-Lie Growth Factor 1
  • Fairborn, Ohio
    Wright State Physicians
Jan 9, 2023

Periodontal Diseases Trial in Catania (Full mouth Scaling and root planing, Quadrant Scaling and root planing)

Completed
  • Periodontal Diseases
  • Full mouth Scaling and root planing
  • Quadrant Scaling and root planing
  • Catania, Italy
    AOU Policlinico G. Rodolico
Feb 8, 2023

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023